返回 
加入收藏
重点监控药品合理用药管理指标体系的构建
x
请在关注微信后，向客服人员索取文件
| 篇名： | 重点监控药品合理用药管理指标体系的构建 |
| TITLE： | Construction of management index system for rational drug use of key monitoring drugs |
| 摘要： | 目的 构建重点监控药品合理用药管理指标体系，为医疗机构重点监控药品的管理提供参考。方法通过文献调研初步拟定重点监控药品合理用药管理指标框架；采用改进德尔菲法，选择20名经验丰富的药学、医务、医保和财务专家，进行2轮问卷咨询，根据专家积极系数、权威系数、意见集中程度和协调程度，确定最终指标，建立医疗机构重点监控药品合理用药管理指标体系。结果2轮咨询中，专家积极系数均为100%；一、二、三级指标的专家权威系数分别为0.89、0.86和0.87，重要性评分专家协调系数分别为0.300（P＜0.05）、0.125（P＜0.05）和0.139（P＜0.05）。所有指标的重要性评分均值均大于3.5分，满分比为35%～100%，变异系数除三级指标“重点监控药品采购品规数”为0.26外，其余均不大于0.25。根据专家咨询结果，最终建立包含2个一级指标（药品采购使用和合理用药）、5个二级指标（可及性、经济性等）、20个三级指标（重点监控药品采购品规数、重点监控药品费用增幅等）的重点监控药品合理用药管理指标体系。结论本研究建立的医疗机构重点监控药品合理用药管理指标体系具有较高的可靠性和较强的可操作性，可作为医疗机构重点监控药品管理的参考依据。 |
| ABSTRACT： | OBJECTIVE To establish management index system for rational drug use of key monitoring drugs， and provide reference for the management of key monitoring drugs in the hospitals. METHODS First， the management index system for rational drug use of key monitoring drugs was drafted by collecting the evidence from related medical literature. Next， using a modified Delphi method， twenty experienced experts from the fields of pharmacy， medical practice， healthcare insurance， and finance were selected to participate in two rounds of questionnaire consultations. Based on the expert enthusiasm coefficient， authority coefficient， degree of opinion concentration， and degree of coordination， the final indicators were determined to establish a management index system for rational drug use of key monitored drugs in medical institutions. RESULTS The expert enthusiasm coefficients reached 100% in both rounds of consultation. In first-level， second-level and third-level indicators， the authority coefficients of experts were 0.89， 0.86 and 0.87， and coordination coefficients of the experts in importance score were 0.300 （P＜ 0.05）， 0.125 （P＜0.05） and 0.139 （P＜0.05）， respectively. The average score for the importance of all indicators reached over 3.5， in which the full score ratio ranged from 35% to 100%. Except that the variation coefficient of a third-level indicator “number of specifications purchased for key monitored drugs” was 0.26， the variation coefficients of rest indicators were less than or equal to 0.25. Based on the results of expert consultation， final version of the management index system established in this study， including two first-level indicators （drug procurement and use， and rational drug use）， five second-level indicators （such as the accessibility， cost-effectiveness） and twenty third-level indicators （such as the number of specifications purchased for key monitored drugs， the increase in the cost of key monitored drugs）. CONCLUSIONS The management index system established in this study possesses high reliability and strong operability， and may provide a reference for the management of key monitoring drugs in the hospitals. |
| 期刊： | 2025年第36卷第07期 |
| 作者： | 张明雄；秦婉莹；黄健；王丹；李莉；卜莹慧；颜铭；李珂佳 |
| AUTHORS： | ZHANG Mingxiong，QIN Wanying，HUANG Jian，WANG Dan，LI Li，BU Yinghui，YAN Ming，LI Kejia |
| 关键字： | 重点监控药品；改进德尔菲法；合理用药；指标体系 |
| KEYWORDS： | key monitoring drugs； modified Delphi |
| 阅读数： | 4 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
